Market Overview:
The global Alfacalcidol market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into liquid and capsule. On the basis of application, the market is segmented into retail pharmacies, hospital pharmacies and online pharmacies. The North American region dominates the global Alfacalcidol market followed by Europe due to rising prevalence of chronic diseases in these regions.
Product Definition:
Alfacalcidol is a synthetic form of vitamin D that is used to treat calcium and phosphate deficiencies. It helps the body to absorb food and use calcium and phosphorus to build bones.
Liquid:
Liquid is the carrier that allows the drug to be administered in a specific manner. It may comprise solvents, emulsifiers, preservatives and/or carriers. The type of liquid used depends on the dosage form which is to be administered such as solutions, suspensions or emulsions among others.
The growth factor for liquid in alfacalcidol market is its administration route which includes oral tablets or by injection (intravenous).
Capsule:
Capsule is a small container that holds the drug and protects it from getting damaged. It also helps in delivering the right amount of drug to the patient at desired time. Capsules are available in different sizes, shapes and colors depending upon its use. The size of capsule depends on its fill weight which can be anywhere between 0.5 mg to 500 mg for oral drugs or 2 ml to 20 ml for injectable drugs (intravenous).
Application Insights:
The retail pharmacies segment held the largest share of more than 60.0% in 2017. The segment is expected to witness significant growth over the forecast period owing to increasing healthcare spending by consumers and rising incidences of heart diseases, which require medication, especially aspirin and calcium supplements among other drugs.
In addition, growing awareness about health issues coupled with a rise in disposable income among working-class adults will boost alfacalcidol demand from retail pharmacies over the forecast period. However, high production costs may limit its application scope in this sector as compared to hospital pharmacies or online pharmacies due to higher purchasing power of consumers who prefer buying medicines from these sectors due to convenience and accessibility offered at affordable prices along with full product information on website directly related with medicine effects without any intermediaries or doctors consultation fees charged extra for it which is expected fuel market growth during future years.
On average across various countries worldwide including U.S.
Regional Analysis:
Europe dominated the global alfacalcidol market in 2017. The presence of key players, favorable reimbursement policies, and increasing number of online pharmacies are some factors contributing to the growth in this region. In 2016, there were around 1.5 million retail pharmacies across Europe that sold medicines for over 200 billion Euros a year or around 5% of all retail pharmacies in the EU [ ]. Increasing demand for generic drugs due to patent expiration is expected to drive competition among European manufacturers during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in healthcare expenditure and prevalence of cardiovascular diseases & cancer among others as well as growing geriatric population (65 years old above) which require treatment with calcitriol analogs such as alfacalcidol tablets (ALCETAR). Moreover, rising awareness about advanced therapies using calcitriol analogs will fuel regional product demand during 2018 - 2030 time frame.
Growth Factors:
- Increasing prevalence of vitamin D deficiency: Alfacalcidol is used for the treatment of vitamin D deficiency. The increasing prevalence of vitamin D deficiency is expected to drive the growth of the alfacalcidol market.
- Rising awareness about the benefits of alfacalcidol: There is a growing awareness about the benefits of alfacalcidol, which is expected to drive its demand in the coming years.
- Growing use of alfacalcidol in pediatric population: Alfacalcidol is increasingly being used in pediatric population for treating various diseases and disorders associated with calcium and phosphorus metabolism, bone health, and muscle function. This is likely to boost the growth prospects of this market in future.
- Technological advancements in production process: The technological advancements taking place in production process are likely to propel market growth over forecast period as it would help reduce manufacturing cost and make this drug available at affordable prices globally.. 5 Emerging markets offer lucrative opportunities: The emerging markets offer lucrative opportunities for players operating in this market as these regions are witnessing a high rateof adoptionof new technologiesand rising disposable incomes that support increased spending on healthcare products
Scope Of The Report
Report Attributes
Report Details
Report Title
Alfacalcidol Market Research Report
By Type
Liquid, Capsule
By Application
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
By Companies
Abcam, YaoPharma, Kunming Baker Norton Pharmaceutical, Teva, Leo Pharma, Tocris Bioscience, LGM Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Alfacalcidol Market Report Segments:
The global Alfacalcidol market is segmented on the basis of:
Types
Liquid, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- YaoPharma
- Kunming Baker Norton Pharmaceutical
- Teva
- Leo Pharma
- Tocris Bioscience
- LGM Pharma
Highlights of The Alfacalcidol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid
- Capsule
- By Application:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alfacalcidol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alfacalcidol is a medication used to treat high blood pressure. It works by lowering blood pressure by widening the arteries and reducing the amount of fluid that flows through them. Alfacalcidol is also known as an ACE inhibitor, which stands for angiotensin converting enzyme inhibitors.
Some of the major players in the alfacalcidol market are Abcam, YaoPharma, Kunming Baker Norton Pharmaceutical, Teva, Leo Pharma, Tocris Bioscience, LGM Pharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Alfacalcidol Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Alfacalcidol Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Alfacalcidol Market - Supply Chain
4.5. Global Alfacalcidol Market Forecast
4.5.1. Alfacalcidol Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Alfacalcidol Market Size (000 Units) and Y-o-Y Growth
4.5.3. Alfacalcidol Market Absolute $ Opportunity
5. Global Alfacalcidol Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Alfacalcidol Market Size and Volume Forecast by Type
5.3.1. Liquid
5.3.2. Capsule
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Alfacalcidol Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Alfacalcidol Market Size and Volume Forecast by Application
6.3.1. Retail Pharmacies
6.3.2. Hospital Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Alfacalcidol Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Alfacalcidol Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Alfacalcidol Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Alfacalcidol Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Alfacalcidol Demand Share Forecast, 2019-2026
9. North America Alfacalcidol Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Alfacalcidol Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Alfacalcidol Market Size and Volume Forecast by Application
9.4.1. Retail Pharmacies
9.4.2. Hospital Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Alfacalcidol Market Size and Volume Forecast by Type
9.7.1. Liquid
9.7.2. Capsule
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Alfacalcidol Demand Share Forecast, 2019-2026
10. Latin America Alfacalcidol Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Alfacalcidol Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Alfacalcidol Market Size and Volume Forecast by Application
10.4.1. Retail Pharmacies
10.4.2. Hospital Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Alfacalcidol Market Size and Volume Forecast by Type
10.7.1. Liquid
10.7.2. Capsule
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Alfacalcidol Demand Share Forecast, 2019-2026
11. Europe Alfacalcidol Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Alfacalcidol Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Alfacalcidol Market Size and Volume Forecast by Application
11.4.1. Retail Pharmacies
11.4.2. Hospital Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Alfacalcidol Market Size and Volume Forecast by Type
11.7.1. Liquid
11.7.2. Capsule
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Alfacalcidol Demand Share, 2019-2026
12. Asia Pacific Alfacalcidol Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Alfacalcidol Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Alfacalcidol Market Size and Volume Forecast by Application
12.4.1. Retail Pharmacies
12.4.2. Hospital Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Alfacalcidol Market Size and Volume Forecast by Type
12.7.1. Liquid
12.7.2. Capsule
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Alfacalcidol Demand Share, 2019-2026
13. Middle East & Africa Alfacalcidol Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Alfacalcidol Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Alfacalcidol Market Size and Volume Forecast by Application
13.4.1. Retail Pharmacies
13.4.2. Hospital Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Alfacalcidol Market Size and Volume Forecast by Type
13.7.1. Liquid
13.7.2. Capsule
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Alfacalcidol Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Alfacalcidol Market: Market Share Analysis
14.2. Alfacalcidol Distributors and Customers
14.3. Alfacalcidol Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abcam
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. YaoPharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kunming Baker Norton Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Leo Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tocris Bioscience
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. LGM Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
